Literature DB >> 18386930

Differentiating proteomic biomarkers in breast cancer by laser capture microdissection and MALDI MS.

Melinda E Sanders1, Eduardo C Dias, Baogang J Xu, James A Mobley, Dean Billheimer, Heinrich Roder, Julia Grigorieva, Mitchell Dowsett, Carlos L Arteaga, Richard M Caprioli.   

Abstract

We assessed proteomic patterns in breast cancer using MALDI MS and laser capture microdissected cells. Protein and peptide expression in invasive mammary carcinoma versus normal mammary epithelium and estrogen-receptor positive versus estrogen-receptor negative tumors were compared. Biomarker candidates were identified by statistical analysis and classifiers were developed and validated in blinded test sets. Several of the m/ z features used in the classifiers were identified by LC-MS/MS and two were confirmed by immunohistochemistry.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18386930      PMCID： PMC2738605          DOI： 10.1021/pr7008109

Source DB:  PubMed          Journal:  J Proteome Res        ISSN： 1535-3893            Impact factor:   4.466


  43 in total

1.  Identification of protein fragments as pattern features in MALDI-MS analyses of serum.

Authors:  Lisa J Zimmerman; Gregory R Wernke; Richard M Caprioli; Daniel C Liebler
Journal:  J Proteome Res       Date:  2005 Sep-Oct       Impact factor: 4.466

2.  TAILORx: trial assigning individualized options for treatment (Rx).

Authors:  Joseph A Sparano
Journal:  Clin Breast Cancer       Date:  2006-10       Impact factor: 3.225

3.  A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer.

Authors:  Soonmyung Paik; Steven Shak; Gong Tang; Chungyeul Kim; Joffre Baker; Maureen Cronin; Frederick L Baehner; Michael G Walker; Drew Watson; Taesung Park; William Hiller; Edwin R Fisher; D Lawrence Wickerham; John Bryant; Norman Wolmark
Journal:  N Engl J Med       Date:  2004-12-10       Impact factor: 91.245

4.  Expression of S100 proteins in normal human tissues and common cancers using tissue microarrays: S100A6, S100A8, S100A9 and S100A11 are all overexpressed in common cancers.

Authors:  S S Cross; F C Hamdy; J C Deloulme; I Rehman
Journal:  Histopathology       Date:  2005-03       Impact factor: 5.087

5.  Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer.

Authors:  Yixin Wang; Jan G M Klijn; Yi Zhang; Anieta M Sieuwerts; Maxime P Look; Fei Yang; Dmitri Talantov; Mieke Timmermans; Marion E Meijer-van Gelder; Jack Yu; Tim Jatkoe; Els M J J Berns; David Atkins; John A Foekens
Journal:  Lancet       Date:  2005 Feb 19-25       Impact factor: 79.321

6.  High nuclear S100A6 (Calcyclin) is significantly associated with poor survival in pancreatic cancer patients.

Authors:  Dale Vimalachandran; William Greenhalf; Christopher Thompson; Jutta Lüttges; Wendy Prime; Fiona Campbell; Andrew Dodson; Richard Watson; Tatjana Crnogorac-Jurcevic; Nicholas Lemoine; John Neoptolemos; Eithne Costello
Journal:  Cancer Res       Date:  2005-04-15       Impact factor: 12.701

7.  Biomarker discovery by imaging mass spectrometry: transthyretin is a biomarker for gentamicin-induced nephrotoxicity in rat.

Authors:  Hélène Meistermann; Jeremy L Norris; Hans-Rudolf Aerni; Dale S Cornett; Arno Friedlein; Annette R Erskine; Angélique Augustin; Maria Cristina De Vera Mudry; Stefan Ruepp; Laura Suter; Hanno Langen; Richard M Caprioli; Axel Ducret
Journal:  Mol Cell Proteomics       Date:  2006-05-16       Impact factor: 5.911

8.  Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials.

Authors: 
Journal:  Lancet       Date:  2005 May 14-20       Impact factor: 79.321

Review 9.  New developments in profiling and imaging of proteins from tissue sections by MALDI mass spectrometry.

Authors:  Pierre Chaurand; Jeremy L Norris; D Shannon Cornett; James A Mobley; Richard M Caprioli
Journal:  J Proteome Res       Date:  2006-11       Impact factor: 4.466

10.  Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer.

Authors:  Martine J Piccart-Gebhart; Marion Procter; Brian Leyland-Jones; Aron Goldhirsch; Michael Untch; Ian Smith; Luca Gianni; Jose Baselga; Richard Bell; Christian Jackisch; David Cameron; Mitch Dowsett; Carlos H Barrios; Günther Steger; Chiun-Shen Huang; Michael Andersson; Moshe Inbar; Mikhail Lichinitser; István Láng; Ulrike Nitz; Hiroji Iwata; Christoph Thomssen; Caroline Lohrisch; Thomas M Suter; Josef Rüschoff; Tamás Suto; Victoria Greatorex; Carol Ward; Carolyn Straehle; Eleanor McFadden; M Stella Dolci; Richard D Gelber
Journal:  N Engl J Med       Date:  2005-10-20       Impact factor: 91.245
View more
  28 in total

1.  S100-A10, thioredoxin, and S100-A6 as biomarkers of papillary thyroid carcinoma with lymph node metastasis identified by MALDI imaging.

Authors:  Martin Nipp; Mareike Elsner; Benjamin Balluff; Stephan Meding; Hakan Sarioglu; Marius Ueffing; Sandra Rauser; Kristian Unger; Heinz Höfler; Axel Walch; Horst Zitzelsberger
Journal:  J Mol Med (Berl)       Date:  2011-09-22       Impact factor: 4.599

Review 2.  Mass spectrometric imaging for biomedical tissue analysis.

Authors:  Kamila Chughtai; Ron M A Heeren
Journal:  Chem Rev       Date:  2010-05-12       Impact factor: 60.622

Review 3.  Molecular mass spectrometry imaging in biomedical and life science research.

Authors:  Jaroslav Pól; Martin Strohalm; Vladimír Havlíček; Michael Volný
Journal:  Histochem Cell Biol       Date:  2010-10-28       Impact factor: 4.304

4.  Structure of the S100A6 complex with a fragment from the C-terminal domain of Siah-1 interacting protein: a novel mode for S100 protein target recognition.

Authors:  Young-Tae Lee; Yoana N Dimitrova; Gabriela Schneider; Whitney B Ridenour; Shibani Bhattacharya; Sarah E Soss; Richard M Caprioli; Anna Filipek; Walter J Chazin
Journal:  Biochemistry       Date:  2008-09-20       Impact factor: 3.162

5.  Proteomic studies in breast cancer (Review).

Authors:  Xian-Ju Qin; Bruce X Ling
Journal:  Oncol Lett       Date:  2012-01-18       Impact factor: 2.967

6.  Integrated proteomic, transcriptomic, and biological network analysis of breast carcinoma reveals molecular features of tumorigenesis and clinical relapse.

Authors:  Marcin Imielinski; Sangwon Cha; Tomas Rejtar; Elizabeth A Richardson; Barry L Karger; Dennis C Sgroi
Journal:  Mol Cell Proteomics       Date:  2012-01-12       Impact factor: 5.911

Review 7.  Laser capture microdissection: Big data from small samples.

Authors:  Soma Datta; Lavina Malhotra; Ryan Dickerson; Scott Chaffee; Chandan K Sen; Sashwati Roy
Journal:  Histol Histopathol       Date:  2015-04-20       Impact factor: 2.303

8.  Enhanced interferon signaling pathway in oral cancer revealed by quantitative proteome analysis of microdissected specimens using 16O/18O labeling and integrated two-dimensional LC-ESI-MALDI tandem MS.

Authors:  Lang-Ming Chi; Chien-Wei Lee; Kai-Ping Chang; Sheng-Po Hao; Hang-Mao Lee; Ying Liang; Chuen Hsueh; Chia-Jung Yu; I-Neng Lee; Yin-Ju Chang; Shih-Ying Lee; Yuan-Ming Yeh; Yu-Sun Chang; Kun-Yi Chien; Jau-Song Yu
Journal:  Mol Cell Proteomics       Date:  2009-03-18       Impact factor: 5.911

9.  Mass spectrometry protein expression profiles in colorectal cancer tissue associated with clinico-pathological features of disease.

Authors:  Christopher C L Liao; Nicholas Ward; Simon Marsh; Tan Arulampalam; John D Norton
Journal:  BMC Cancer       Date:  2010-08-06       Impact factor: 4.430

10.  Identification of a putative protein profile associated with tamoxifen therapy resistance in breast cancer.

Authors:  Arzu Umar; Hyuk Kang; Annemieke M Timmermans; Maxime P Look; Marion E Meijer-van Gelder; Michael A den Bakker; Navdeep Jaitly; John W M Martens; Theo M Luider; John A Foekens; Ljiljana Pasa-Tolić
Journal:  Mol Cell Proteomics       Date:  2009-03-27       Impact factor: 5.911
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.